|
Status |
Public on Nov 02, 2015 |
Title |
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [ChIP-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Using UNC0638 and genetic assays to inhibit EHMT1/2 and derepress fetal hemoglobin in adult hematopoietic cells.
|
|
|
Overall design |
ChIP-seq for 2 histone modifications and total H3 (for quantitative normalization) in biological triplicates of cord blood, adult bone marrow, and UNC0638-treated adult bone marrow.
|
|
|
Contributor(s) |
Renneville A, Van Galen P, Canver MC, McConkey M, Krill-Burger JM, Dorfman DM, Holson EB, Bernstein BE, Orkin SH, Bauer DE, Ebert BL |
Citation(s) |
26320100 |
|
Submission date |
Jun 03, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Peter van Galen |
E-mail(s) |
[email protected], [email protected]
|
Organization name |
Brigham and Women's Hospital / Broad Institute of MIT and Harvard
|
Department |
Hematology
|
Lab |
Van Galen Lab
|
Street address |
4 Blackfan Circle
|
City |
Boston |
State/province |
Massachusetts |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (2) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (72)
|
|
This SubSeries is part of SuperSeries: |
GSE71422 |
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression |
|
Relations |
BioProject |
PRJNA285772 |
SRA |
SRP059032 |